2 terminated, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow PM 00104: new trials by email Literature Review of PM 00104 trials Research Report on PM 00104
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy Zalypsis - Ewing's Sarcoma, Primitive Neuroectodermal Tumor (PNET) | Phase 2 | Completed | PharmaMar | 17 | 2010-12-01 | 2021-10-29 |
| Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy Zalypsis ( PM00104) - Uterine Cervical Cancer, Endometrial Cancer | Phase 2 | Terminated | PharmaMar | 19 | 2009-08-01 | 2021-10-28 |
| A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma PM00104 - Solid Tumors, Lymphoma | Phase 1 | Terminated | PharmaMar | 12 | 2006-05-01 | 2021-07-28 |
Neoplasms (2) · Endometrial Neoplasms (1) · Lymphoma (1) · Neuroectodermal Tumors, Primitive (1) · Sarcoma, Ewing (1) · Uterine Cervical Neoplasms (1)
PharmaMar (3)
United States (3) · France (1) · Italy (1)
Armando Santoro, Prof. (1) · Eunice Lee Kwak, MD (1) · Fariba Navid, MD (1) · Jean Yves Blay, MD (1) · Paolo Casali, MD (1) · Robin L. Jones, MD (1) · Roger Bryan Cohen, MD (1) · Sant P Chawla, MD (1) · Stefano Ferrari, MD (1)